Researchers at the University of Michigan (U-M) have developed a system that leverages both AI and machine learning to create a…
LIXTE is developing a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments Its lead compound, LB-100, targets…
Scientists at Southampton University have created new antibodies that supercharge the immune system’s ability to identify and kill cancer cells. This approach involved clustering…
Earth Science Tech operates a diversified, revenue-generating holding company model with core exposure to pharmaceutical compounding and telemedicine markets. The…
Behçet’s disease is characterized by unpredictable flare-ups and periods of remission, making long-term management particularly challenging. Current treatment strategies for…
The recent vaccine policy changes that the U.S. government announced have astounded experts because the changes reduce recommended vaccines by one third and put…
The normal practice after someone has undergone a surgical procedure has been to administer anti-inflammatory medications. However, new research conducted…
CTCL is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early stages. Delayed…
A new collaboration between Penn State College of Medicine and Targepeutics seeks to advance research into a promising combination therapy that offers hope to families…
Immunotherapy has emerged as a more gentle way to treat cancer over the past few years. However, it is very expensive and results are usually inconsistent…